Fiel, Milky Jane .
HRN: 12-73-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/29/2025
06/04/2025
IV
600 Mg
Q8
Cellulitis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes